Susquehanna International Group, LLP Alector, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$527 Billion
Q2 2024

Call Options

16 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 07, 2024	SELL	$5.69 - $8.08 $58,607 - $83,224	-10,300 Reduced 45.18%	12,500 $75,000
Q4 2023 Feb 14, 2024	SELL	$3.77 - $8.39 $35,815 - $79,705	-9,500 Reduced 29.41%	22,800 $181,000
Q3 2023 Nov 14, 2023	BUY	$5.2 - $8.77 $115,440 - $194,694	22,200 Added 219.8%	32,300 $209,000
Q2 2023 Aug 11, 2023	SELL	$5.86 - $7.93 $14,064 - $19,032	-2,400 Reduced 19.2%	10,100 $60,000
Q1 2023 May 16, 2023	SELL	$5.85 - $9.84 $837,135 - $1.41 Million	-143,100 Reduced 91.97%	12,500 $77,000
Q4 2022 Feb 14, 2023	SELL	$6.88 - $9.55 $121,776 - $169,035	-17,700 Reduced 10.21%	155,600 $1.44 Million
Q3 2022 Nov 14, 2022	BUY	$8.19 - $13.2 $1.07 Million - $1.72 Million	130,400 Added 303.96%	173,300 $1.64 Million
Q2 2022 Aug 15, 2022	SELL	$7.65 - $14.24 $6,885 - $12,816	-900 Reduced 2.05%	42,900 $436,000
Q1 2022 May 16, 2022	SELL	$13.02 - $20.78 $24,738 - $39,482	-1,900 Reduced 4.16%	43,800 $624,000
Q4 2021 Feb 14, 2022	SELL	$19.35 - $25.54 $2.09 Million - $2.76 Million	-108,000 Reduced 70.27%	45,700 $944,000
Q3 2021 Nov 15, 2021	BUY	$21.65 - $39.49 $1.13 Million - $2.06 Million	52,100 Added 51.28%	153,700 $3.51 Million
Q2 2021 Aug 11, 2021	BUY	$15.5 - $22.48 $545,600 - $791,296	35,200 Added 53.01%	101,600 $2.12 Million
Q4 2020 Feb 16, 2021	SELL	$9.4 - $16.7 $364,720 - $647,960	-38,800 Reduced 36.88%	66,400 $1.01 Million
Q3 2020 Nov 16, 2020	BUY	$10.54 - $24.96 $186,557 - $441,792	17,700 Added 20.23%	105,200 $1.11 Million
Q2 2020 Aug 14, 2020	BUY	$21.87 - $33.11 $1.35 Million - $2.04 Million	61,600 Added 237.84%	87,500 $2.14 Million
Q1 2020 May 15, 2020	BUY	$16.25 - $35.28 $420,875 - $913,752	25,900 New	25,900 $625,000

Others Institutions Holding ALEC

# of Institutions

165

Shares Held

58.1M

Call Options Held

57K

Put Options Held

14.9K

View Full List

About Alector, Inc.

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $406M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

More about ALEC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account